A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System
Clinical trial NCT04179045 · UNKNOWN
Trial details
- NCT number
- NCT04179045
- Sponsor
- Shanghai Bio-heart Biological Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2022-07-01
- Enrollment
- 785
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.